drugset / Trial / NCT05390710
PhI to Solid Tumors and PhII to Locally Advanced or mTNBC
NaSingle-groupOpen-labelTreatment
Summary
PhI Dose Escalation with BOIN design in advanced Solid Tumor with Triple combination therapy to determine MTD and RP2D
Timeline
- Start
- 2021-06-12
- Primary completion
- 2023-12-11
- Completion
- 2023-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Afuresertib | Small molecule | 125 mg | — |
| Subject | LAE005 | Unknown | 1200 mg | Intravenous |
| Subject | Paclitaxel | Small molecule | 125 unknown | — |